Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy.

Tomić M, Ljubić S, Kastelan S.

Coll Antropol. 2013 Apr;37 Suppl 1:51-7.

PMID:
23837221
2.

Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes.

Tomić M, Ljubić S, Kaštelan S, Gverović Antunica A, Jazbec A, Poljičanin T.

Mediators Inflamm. 2013;2013:818671. doi: 10.1155/2013/818671. Epub 2013 Dec 2.

3.

Body mass index: a risk factor for retinopathy in type 2 diabetic patients.

Kaštelan S, Tomić M, Gverović Antunica A, Ljubić S, Salopek Rabatić J, Karabatić M.

Mediators Inflamm. 2013;2013:436329. doi: 10.1155/2013/436329. Epub 2013 Nov 20.

4.

TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.

Gustavsson C, Agardh E, Bengtsson B, Agardh CD.

J Diabetes Complications. 2008 Sep-Oct;22(5):309-16. doi: 10.1016/j.jdiacomp.2007.03.001. Epub 2008 Apr 16.

PMID:
18413212
5.

Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes.

Feghhi M, Nikzamir A, Esteghamati A, Mahmoudi T, Yekaninejad MS.

Transl Res. 2011 Aug;158(2):85-91. doi: 10.1016/j.trsl.2011.03.002. Epub 2011 Apr 1.

PMID:
21757152
6.

Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.

Sasongko MB, Wong TY, Jenkins AJ, Nguyen TT, Shaw JE, Wang JJ.

Diabet Med. 2015 May;32(5):686-91. doi: 10.1111/dme.12640. Epub 2014 Dec 9.

PMID:
25407692
7.

Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.

Hu A, Luo Y, Li T, Guo X, Ding X, Zhu X, Wang X, Tang S.

Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):957-62. doi: 10.1007/s00417-011-1855-x. Epub 2012 Feb 12.

PMID:
22327732
8.

The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus.

Jongsareejit A, Potisat S, Krairittichai U, Sattaputh C, Arunratanachote W.

J Med Assoc Thai. 2013 Nov;96(11):1476-82.

PMID:
24428098
9.

Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus.

Chetthakul T, Deerochanawong C, Suwanwalaikorn S, Kosachunhanun N, Ngarmukos C, Rawdaree P, Krittiyawong S, Leelawatana R, Bunnag P, Plengvidhya N, Pratipanawatr T, Benjasuratwong Y, Mongkolsomlit S.

J Med Assoc Thai. 2006 Aug;89 Suppl 1:S27-36.

PMID:
17715831
10.

Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study.

van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM, Polak BC, Stehouwer CD.

Diabetologia. 2005 Jul;48(7):1300-6. Epub 2005 May 26.

PMID:
15918015
11.

Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project.

Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong TY, Lamoureux EL.

Invest Ophthalmol Vis Sci. 2011 Jun 22;52(7):4416-21. doi: 10.1167/iovs.11-7208.

PMID:
21482643
12.

Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.

Guerci B, Meyer L, Sommer S, George JL, Ziegler O, Drouin P, Angioï-Duprez K.

Diabetes Metab. 1999 Nov;25(5):412-8.

13.

Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients.

Laursen JV, Hoffmann SS, Green A, Nybo M, Sjølie AK, Grauslund J.

Curr Eye Res. 2013 Jan;38(1):174-9. doi: 10.3109/02713683.2012.713153. Epub 2012 Aug 20.

PMID:
22906118
14.

The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.

Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, Lamoureux EL.

Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):677-84. doi: 10.1167/iovs.11-8992.

PMID:
22205611
15.

Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data.

Brunner S, Schernthaner GH, Satler M, Elhenicky M, Hoellerl F, Schmid-Kubista KE, Zeiler F, Binder S, Schernthaner G.

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):392-8. doi: 10.1167/iovs.08-1748. Epub 2008 Aug 21.

PMID:
18719083
16.

Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects.

Woo SJ, Ahn SJ, Ahn J, Park KH, Lee K.

Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7697-703. doi: 10.1167/iovs.11-7784.

PMID:
21873679
17.

The frequency and severity of retinopathy are related to HbA1c values after, but not at, the diagnosis of NIDDM.

Henricsson M, Gottsäter A, Jeppsson JO, Fernlund P, Sundkvist G.

J Intern Med. 1998 Aug;244(2):149-54.

18.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
20.

Body mass index and retinopathy in type 1 diabetic patients.

Kaštelan S, Salopek Rabatić J, Tomić M, Gverović Antunica A, Ljubić S, Kaštelan H, Novak B, Orešković D.

Int J Endocrinol. 2014;2014:387919. doi: 10.1155/2014/387919. Epub 2014 Feb 18.

Items per page

Supplemental Content

Write to the Help Desk